CSTP2

Across TCGA pan-cancer cohorts, CSTP2 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated CSTP2 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher CSTP2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CSTP2 expression acts as an unfavorable survival marker, although some lineages such as COAD and LUAD show a favorable association.

COAD, LUAD, and ACC are the cancer types where CSTP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	II,III,IV	0.939	0.691	<.001	40	view →
LUAD	OS	Median	III,IV	0.796	0.538	.006	19	view →
ACC	DFS	Tertile	II,III,IV	0.068	0.631	.011	18	view →
PCPG	DFS	Tertile	All	0.535	0.936	<.001	18	view →
TGCT	OS	Tertile	All	0.817	0.968	.021	18	view →
THCA	OS	Tertile	IV	0.790	1.000	.016	15	view →
LUSC	OS	Tertile	III,IV	0.306	0.811	.011	10	view →
THYM	OS	Tertile	All	0.593	0.930	.020	9	view →
SKCM	OS	Tertile	III,IV	0.287	0.729	.003	9	view →
SARC	DFS	Tertile	All	0.327	0.520	.039	9	view →
LGG	OS	Tertile	All	0.732	0.899	.012	9	view →
STAD	OS	Quartile	All	0.341	0.495	.020	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

CSTP2–COAD (OS)

Open the COAD breakdown →